Medicare Enrolled
Dr. Scott Kurzrok, DO
Family Medicine · Broomall, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kurzrok from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kurzrok?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kurzrok
Dr. Scott Kurzrok is a family medicine specialist in Broomall, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kurzrok performed 2,094 Medicare services across 1,197 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kurzrok received a total of $20,497 from 73 pharmaceutical and/or device companies across 1354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kurzrok is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 8% volume in PA
$20,497 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,094
Medicare services
Top 8% in PA for family medicine
1,197
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
612 | $91 | $205 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
288 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
266 | $65 | $146 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
134 | $134 | $210 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
123 | $1 | $20 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
99 | $108 | $202 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
71 | $76 | $195 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
68 | $32 | $75 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
57 | $76 | $135 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
48 | $0 | $20 |
| Annual depression screening | 46 | $19 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
40 | $229 | $447 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $85 | $269 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
30 | $16 | $75 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
25 | $52 | $110 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
22 | $87 | $143 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
21 | $5 | $11 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
19 | $61 | $109 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
18 | $50 | $101 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
18 | $51 | $106 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
16 | $31 | $100 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
15 | $40 | $77 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $171 | $268 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $169 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
7.6% medium
90.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,497
Total received (2018-2024)
Avg $2,928/year across 7 years
Top 2% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,435 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$62 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,984
2023
$3,048
2022
$2,576
2021
$2,751
2020
$2,101
2019
$3,045
2018
$3,992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$658
Bayer Healthcare Pharmaceuticals Inc.
$296
AstraZeneca Pharmaceuticals LP
$242
Novo Nordisk Inc
$202
GlaxoSmithKline, LLC.
$200
Novartis Pharmaceuticals Corporation
$197
Almatica Pharma LLC
$156
Corium, LLC
$144
Amgen Inc.
$139
PFIZER INC.
$119
Lilly USA, LLC
$86
Astellas Pharma US Inc
$82
Teva Pharmaceuticals USA, Inc.
$81
Janssen Pharmaceuticals, Inc
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
SHIELD THERAPEUTICS INC
$40
E.R. Squibb & Sons, L.L.C.
$34
Vanda Pharmaceuticals Inc.
$33
Kowa Pharmaceuticals America, Inc.
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Exact Sciences Corporation
$24
IDORSIA PHARMACEUTICALS US INC
$21
AIMMUNE THERAPEUTICS, INC.
$19
Otsuka America Pharmaceutical, Inc.
$16
Phathom Pharmaceuticals, Inc.
$15
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,915
ABBVIE INC.
$1,890
GlaxoSmithKline, LLC.
$1,463
Lilly USA, LLC
$1,360
PFIZER INC.
$1,353
AstraZeneca Pharmaceuticals LP
$1,171
AbbVie Inc.
$950
Novartis Pharmaceuticals Corporation
$856
Amgen Inc.
$743
Boehringer Ingelheim Pharmaceuticals, Inc.
$688
Merck Sharp & Dohme Corporation
$635
Astellas Pharma US Inc
$615
Bayer Healthcare Pharmaceuticals Inc.
$608
Amarin Pharma Inc.
$536
Kowa Pharmaceuticals America, Inc.
$513
Takeda Pharmaceuticals U.S.A., Inc.
$486
Janssen Pharmaceuticals, Inc
$389
Teva Pharmaceuticals USA, Inc.
$387
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$332
IDORSIA PHARMACEUTICALS US INC
$259
Bayer HealthCare Pharmaceuticals Inc.
$254
Corium, LLC
$251
Allergan, Inc.
$246
AbbVie, Inc.
$230
Otsuka America Pharmaceutical, Inc.
$221
Merck Sharp & Dohme LLC
$180
Almatica Pharma LLC
$180
Abbott Laboratories
$151
SANOFI-AVENTIS U.S. LLC
$115
Forte Bio-Pharma LLC
$96
Eisai Inc.
$90
Biohaven Pharmaceuticals, Inc.
$82
Mylan Specialty L.P.
$82
E.R. Squibb & Sons, L.L.C.
$69
BioDelivery Sciences International, Inc.
$62
Biohaven Pharmaceutical Holding Company Ltd.
$62
Allergan Inc.
$53
Pernix Therapeutics Holdings, Inc.
$50
Purdue Pharma L.P.
$46
Circassia Pharmaceuticals Inc
$45
Exact Sciences Corporation
$45
Boston Scientific Corporation
$42
Synergy Pharmaceuticals Inc
$42
Shire North American Group Inc
$42
SHIELD THERAPEUTICS INC
$40
Sunovion Pharmaceuticals Inc.
$38
Scilex Pharmaceuticals Inc.
$35
Vanda Pharmaceuticals Inc.
$33
West-Ward Pharmaceuticals
$31
Phathom Pharmaceuticals, Inc.
$28
ARBOR PHARMACEUTICALS, INC.
$28
Ferring Pharmaceuticals Inc.
$27
Horizon Pharma plc
$27
Horizon Therapeutics plc
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Sun Pharmaceutical Industries Inc.
$21
ITI, Inc.
$19
Dexcom, Inc.
$19
AIMMUNE THERAPEUTICS, INC.
$19
Sanofi Pasteur Inc.
$19
Ultragenyx Pharmaceutical Inc.
$18
Hikma Pharmaceuticals USA
$16
EISAI INC.
$16
Intra-Sana Laboratories
$15
Philips Electronics North America Corporation
$15
VistaPharm, Inc.
$15
Vertical Pharmaceuticals, LLC
$15
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Avanir Pharmaceuticals, Inc.
$13
Collegium Pharmaceutical, Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
Metuchen Pharmaceuticals
$11
Daiichi Sankyo Inc.
$11
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · AZSTARYS · Aimovig · AirDuo Digihaler · Amitiza · Austedo XR · Azstarys · BASAGLAR · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BUNAVAIL 2.1 mg 30-count box · BodyGuardian · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · Creon · Crysvita · DALIRESP · DUAKLIR PRESSAIR · Dayvigo · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · EUCRISA · Edarbi · FANAPT · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · Horizant · INVOKAMET · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kapspargo Sprinkle (metoprolol succinate) · Kerendia · LEQVIO · LINZESS · LIVALO · LOKELMA · LOREEV XR · LORZONE · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Movantik · Myrbetriq · NALOCET · NUEDEXTA · NURTEC ODT · Nalocet · Otezla · Ozempic · PENNSAID · PREVNAR - 13 · Prolia · QULIPTA · QUVIVIQ · REBYOTA · RELTONE 200 MG · REXULTI · REYVOW · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · Seglentis · Stendra · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Thyquidity · Tresiba · Trintellix · Trulance · UBRELVY · Uloric · Utibron · VERQUVO · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xultophy 100/3.6 · Yupelri · ZENPEP · ZOHYDRO ER · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
2,451
Per 100K population
425.4
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kurzrok is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 2% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kurzrok experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kurzrok performed 612 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kurzrok receive payments from pharmaceutical companies?
Yes. Dr. Kurzrok received a total of $20,497 from 73 companies across 1,354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kurzrok's costs compare to other family medicine physicians in Broomall?
Dr. Kurzrok's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kurzrok) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Broomall
Browse family medicine physicians in Broomall ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology